Dishman Pharmaceutical & Chemicals (DISHMAN) manufactures and markets cost-effective, high quality chemical services and products to the global pharmaceutical and chemical industry. It was incorporated on June 29, 1983 as a private limited company and went public on April 1, 1996. The company got its current name On Jan. 1, 1999. Through synthetic chemistry research, the company has developed manufacturing processes for various intermediates, active pharmaceutical ingredients (APIs), quarternary ammonium compounds (QUATS) and specialty chemicals. It is also engaged in pharmaceutical outsourcing which includes contract research and manufacturing (CRAM Segment). Presently, DISHMAN has three manufacturing sites; namely Dishman Pharmaceuticals and Chemicals (Bavla), Dishman Pharmaceuticals and Chemicals (Naroda) and Sch?tz Dishman Biotech (Bavla). DISHMAN has marketing offices/wholly-owned subsidiaries at strategically important global locations. It has two wholly-owned subsidiaries in Europe and US called Dishman Europe and Dishman USA, Inc. The company acquired Carbogen Amcis AG (CA), a Swiss research-based company with three production facilities in Switzerland for the manufacture of high-potent, high-value products. It has representative offices in Germany, Italy and Turkey. The client list includes global pharma and agro blue chip majors. The company received the Greentech Environment Excellence Award?2006 (silver category award in chemical sector) for outstanding achievement towards environment protection and clean environment in the industrial and service industry. The registered office of the company is at Bhadr-Raj Chambers, Swastik Cross Road, Navrangpura, Ahmedabad-380009, Gujarat.
You
should Trade Less But Trade Accurately & this is Achieved with our Tip.
